|
1. Bilezikian JP, Marcus R, Levine
MA., Eds. The parathyroids, basic and clinical concepts. Raven Press,
New York; 1-841, 1994. 2. Thompson NW, Eckauser FE, Marness JK. The
anatomy of primary hyperparathyroidism. 92:814, 1982. 3. Potts JT,
Kronenberg HM, Rosemblatt M. Parathyroid hormone: chemistry, biosyntesis
and mode of action. Adv Protein Chem 35:323, 1982. 4. Brown EM, Gamba
G, Riccardi D, Lombardi D, Butters R, Kifor O, Sun A, Hediger MA,
Lytton J, Herbert SC. Cloning and characterization of an extracellular
Ca2+ sensing receptor from bovine parathyroid. Nature 366:575, 1993.
5. McSheehy PMGJ, Chambers TJ. Osteoblastic cells mediate osteoblastic
responsiveness parathyroid hormone. Endocrinology 118:824, 1986. 6.
Juppner H, Abou-Samra AB, Freeman M et al. A G protein linked receptor
for parathyroid hormone and parathyroid related peptide. Science 254:1024,
1991. 7. Arnold A, Staunton CE, Kim MG et al. Monoclonality an abnormal
parathyroid hormone gene in parathyroid adenomas. New Engl J Med 318:658,
1988. 8. Falchetti A, Bale A, Amorosi A et al. Progression of uremic
hyperparathyroidism involves allelic loss on chromosome 11. J Clin
Endocrinol Metab 76:139, 1993. 9. Chandrasekarappa SC, Stradanalli
CG; Packiappan M et al. Positional cloning of the gene for multiple
endocrine neoplasia type 1. Science 276:404, 1997. 10. Pollack MR,
Brown EM Chou Y-M, et al. Mutations of the human Ca2+ sensing receptor
gene cause familiar hypocalciuric hypercalcemia and neonatal severe
hyperparathyroidism. Cell 75:1297, 1993. 11. Carling T, Szabo E, Bai
M et al. Familial hypercalcemia and hypercalciuria caused by a novel
mutation in the cytoplasmic tail of the calcium receptor. J Clin Endocrinol
Metab 85:2042, 200. 12. Proceedings of the NIH Consensus Development
Conference on Diagnosis and Management of Asymptomatic Primary Hyperparathyroidism.
J Bone Miner Res 6, suppl. 2, 1991. 13. Silverberg SJ, Bilezikian
JP. Primary hyperparathyroidism: still evolving? J Bone Miner Res
12:856, 1997 14. Ahn TG, Antonarakis SE, Kronenberg HM et al. Familial
isolated hypoparathyroidism: a molecular genetic analysis of 8 families
with 23 affected persons. Medicine 65:73, 1986. 15. Winer KK, Yanouski
JA, Cutler GB. Synthetic human parathyroid hormone 1-34 vs calcitriol
and calcium treatment of hypoparathyroidism. JAMA 276:631, 1986. 16.
Arnold A, Horst SA, Gardella TJ, Baba H, Levine MA, Kronenberg HM:
Mutations of the signal peptide encoding region preproparathyroid
hormone gene in isolated hypoparathyroidism. J Clin Invest 86:1084,
1990. 17. Pollak MR, Brown EM, Estep HL, McLine PN, Kifor O, Park
J, Hebert SC, Seidman CE, Seidman JG: Autosomal dominant hypocalcemia
caused by a Ca2+-sensing receptor gene mutation. Nature Genet 8:303,
1994. 18. Pearce SHS, Williamson C, Kifor O, Bai M, Coulthard MG,
Davies M, Lewis-Barned N, McCredie D, Powell H, Kendall-Taylor P,
Brown EM, Takker RV: A familial syndrome of hypocalcemia with hypocalciuria
due to mutations in the calcium-sensing receptor gene. N Engl J Med
335:115, 1996. 19. Levine MA, Jap T, Mauseth RS: Activity of the stimulatory
guanine nucleotide-binding protein is reduced in erythrocytes from
patients with pseudo-hypoparathyroidism and pseudopseudohypoparathyroidism:
biochemical, endocrine and genetic analysis of Albright's hereditary
osteodystrophy in six kindreds. J Clin Endocrinol Metab 62: 497, 1986.
20. Drezner MK, Neelon FA, Lebovitz HE: Pseudohypoparathyroidism type
II: a possible defect in the reception of the cyclic AMP signal. N
Engl J Med 280:1056, 1973.
|
